Overview

Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children

Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Levobupivacaïne (Chirocaine®) is a new local anaesthetic recently marketed in France. The goal of this prospective work is to study the pharmacokinetic aspect of this drug after injection around the sciatic nerve (subgluteal way).
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Treatments:
Bupivacaine
Levobupivacaine